Ignite Creation Date:
2024-05-06 @ 8:18 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06338111
Status:
COMPLETED
Last Update Posted:
2024-06-07
First Post:
2024-03-23
Brief Title:
Can we Improve Mortality Prediction in Patients With Sepsis in the Emergency Department
Sponsor:
Iuliu Hatieganu University of Medicine and Pharmacy
Organization:
Iuliu Hatieganu University of Medicine and Pharmacy
Study Overview
Official Title:
Can we Improve Mortality Prediction in Patients With Sepsis in the Emergency Department
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to identify the prognostic role of procalcitonin PCT soluble Triggering Receptor Expressed on Myeloid Cells-1 sTREM-1 the soluble form of the urokinase plasminogen activator receptor suPAR highly sensitive C-reactive protein hs-CRP Interleukin-6 IL-6 and azurocidin 1 AZU1 in 28-day mortality for patients with sepsis in Emergency Department
Detailed Description:
The levels of the specified biomarkers were measured upon patient arrival at the Emergency Department ED and analyzed their correlation with 28-day mortality The values of these biomarkers were monitored over the initial three days following admission to the ED aiming to explore their potential in guiding the de-escalation of antibiotic treatment Considering their prognostic significance the main goal is to develop a novel scoring system tailored for use in the emergency department setting
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None